This study investigates a treatment for pancreatic cancer using an intratumoral device that emits alpha radiation. The purpose is to evaluate this approach for individuals with advanced stages of the condition.
The focus of this study is to assess the safety and feasibility of using alpha radiation emitted directly into the tumor. It evaluates the potential effects and outcomes for patients undergoing this treatment.
- Who can participate: Adults aged 18 and older with advanced pancreatic cancer may qualify. Participants must have a life expectancy of more than 6 months.
- Study details: Participants will undergo a procedure to insert the alpha radiation emitter device into their tumor.
- Study timelines: The study will last 24 months.
How understandable was the trial content above?
Hard to understand
Easy to understand